Robert M. Anglin

Robert M. Anglin appears in our data through filings on Rochester Medical Corporation shares, published by SEC (Form 4). Over a trading history stretching from 7 September 2010 to 14 November 2013, the count stands at 8 filings.

The open-market record consists of 2 sales worth €101k, with no purchase. Besides market trades, the filings include 1 share grant and 4 option exercises. So far in 2013, the count stands at no purchases and 1 sale.

Most recently, on 18 November 2013, the filings show a share grant in Rochester Medical Corporation. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.